Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.70B | 13.38B | 12.48B | 12.19B | 11.07B | Gross Profit |
7.42B | 6.47B | 6.00B | 5.46B | 5.16B | EBIT |
3.83B | 3.79B | 3.67B | 2.09B | 2.78B | EBITDA |
4.94B | 3.91B | 3.81B | 2.44B | 3.21B | Net Income Common Stockholders |
2.65B | 2.56B | 2.59B | 1.25B | 1.97B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.30B | 1.15B | 1.14B | 836.00M | 1.19B | Total Assets |
48.97B | 33.96B | 32.70B | 31.93B | 32.11B | Total Debt |
17.70B | 12.03B | 11.46B | 10.16B | 8.63B | Net Debt |
16.62B | 11.25B | 10.77B | 9.62B | 7.74B | Total Liabilities |
42.53B | 34.70B | 33.13B | 30.77B | 28.52B | Stockholders Equity |
6.12B | -826.00M | -529.00M | 1.06B | 3.50B |
Cash Flow | Free Cash Flow | |||
2.82B | 3.18B | 3.02B | 2.04B | 2.64B | Operating Cash Flow |
3.04B | 3.44B | 3.22B | 2.18B | 2.78B | Investing Cash Flow |
-2.83B | -188.00M | -449.00M | 49.00M | -679.00M | Financing Cash Flow |
796.00M | -2.87B | -1.79B | -1.92B | -2.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $82.97B | 49.51 | 9.46% | 0.74% | 15.21% | 46.99% | |
78 Outperform | $116.40B | 12.91 | 15.01% | 1.23% | 11.78% | 4.39% | |
77 Outperform | $33.73B | 34.63 | 16.35% | 0.47% | 12.89% | 13.50% | |
76 Outperform | $116.02B | 28.77 | 31.80% | 1.33% | 7.60% | 8.66% | |
73 Outperform | $86.34B | 31.95 | 100.25% | 0.68% | 17.51% | 1.31% | |
71 Outperform | $48.43B | 16.18 | 7.10% | 1.90% | -28.56% | 1.14% | |
64 Neutral | $13.80B | 10.64 | 9.23% | 4.22% | 17.66% | -7.66% |